Cellular Adaptations, Injury, and Intracellular Accumulations in Pathology

Pathology Course Introduction and Overview

  • Instructor Introduction: Dr. Leslie Torgerson is an APCP (Anatomic Pathology and Clinical Pathology) certified pathologist. She was raised in Texas (Texas A&M), completed an Army residency in Honolulu, Hawaii, and served at Wilford Hall and Penrose Hospital (Colorado Springs). She was the residency director for six years and provides guidance on the residency application process.

  • Teaching Faculty: TCM (Transitions to Clinical Medicine) is taught by Dr. Leslie Torgerson, Dr. Kelly, Dr. Henderson, and Dr. Gubler.

  • Course Structure and Resources:

    • Textbook: Robbins & Cotran Pathologic Basis of Disease is the primary text.

    • Lecture Format: Lectures are broken into smaller segments to prevent burnout, though some modules (like Heme) are necessarily longer.

    • Clinical Integration sessions (CIS): Held on Wednesdays before exams. These involve reviews of test questions and cases to emphasize high-yield material.

    • Assessments: Four Canvas quizzes (open resource: PowerPoints, textbooks, and peer collaboration encouraged; internet use discouraged). UWorld questions are provided for advanced practice; they are more difficult than the TCM exams but prepare students for Board (USMLE/COMLEX) and shelf exams.

Fundamental Concepts of Pathology

  • Definition of Pathology: Pathology is the basic science of clinical medicine. It is the study of the loss of homeostasis through structural, biochemical, and morphological changes in cells, tissues, and organs.

  • Etymology: Derived from the Greek pathos (disease) and logo (study).

  • The Four Pillars of Pathology:

    1. Etiology: The cause or initiation of disease. This can be genetic, environmental (infectious, nutritional, chemical, physical), or idiopathic (unknown cause).

    2. Pathogenesis: The mechanism of disease development; the specific biochemical or cellular events leading to the disease state.

    3. Morphology: The structural changes in cells and tissues (gross and microscopic findings).

    4. Clinical Significance: How the structural/biochemical changes affect the patient, leading to clinical signs and symptoms.

  • Subspecialties of Pathology:

    • Anatomic Pathology: Focuses on gross and microscopic examination of tissues and autopsies.

    • Clinical Pathology: Manages laboratory testing and transfusion services.

  • Thinking Like a Physician: The diagnostic process follows a logical progression:

    • Clinical history and physical exam.

    • Development of a differential diagnosis.

    • Narrowing the differential via additional history, specific physical exams, labs, radiology, and biopsies.

    • Providing patient-centered answers: "Why me?" (risk factors, genetics, environment), natural history of the disease, and treatment options/outcomes.

Cellular Adaptations to Stress

  • Rudolf Virchow: Known as the Father of Pathology, he posited that all cells come from cells and all diseases arise from the loss of cellular homeostasis.

  • Homeostasis: A dynamic equilibrium where a living organism adjusts its internal environment to remain stable.

  • Adaptation: A new, reversible state of equilibrium in response to a stressor. If adaptive limits are exceeded, or if damage is too severe (hypoxia, nutrient deprivation, mutation), cell injury occurs.

  • Cell Injury Spectrum:

    1. Reversible Injury: Mild stress; cells return to normal if the stress is removed.

    2. Irreversible Injury (Cell Death): Severe stress leads to necrosis or apoptosis.

  • Types of Adaptations: Size (hypertrophy/atrophy), Number (hyperplasia), Phenotype/Activity (metaplasia).

Hypertrophy: Increase in Cell Size

  • Definition: Increase in the size of cells resulting in an increase in the size of the organ. Common in non-dividing cells.

  • Physiologic Hypertrophy: Normal response to increased functional demand.

    • Example: Skeletal muscle in weightlifters or marathon runners.

    • Example: Uterus during pregnancy (estrogen-induced growth of smooth muscle).

  • Pathologic Hypertrophy: Abnormal response to disease or chronic stressors.

    • Left Ventricular Hypertrophy (LVH): Caused by hypertension or a stenotic aortic valve. The heart works harder to pump against pressure.

    • Histology: Boxcar-shaped nuclei (enlarged, rectangular nuclei due to DNA synthesis without mitosis).

    • Limitations: While initially beneficial, pathologic hypertrophy leads to tenuous oxygen supply (thick myocytes exceed capillary density), resulting in ischemia, fibrosis, and heart failure.

Hyperplasia: Increase in Cell Number

  • Definition: Increase in the number of cells in an organ/tissue, occurring only in cells capable of division.

  • Physiologic Hyperplasia:

    • Compensatory: Liver regrowth after resection; skin callus formation from friction.

    • Compensatory Erythroid: Bone marrow increases red cell precursors in response to low oxygen tension (O2O_2) at high altitudes or anemia.

    • Hormonal: Breast lobule proliferation during pregnancy/lactation (progesterone-driven).

  • Pathologic Hyperplasia:

    • HPV (Human Papillomavirus): Causes skin warts through excessive keratinocyte proliferation.

    • Endometrial Hyperplasia: Caused by unopposed estrogen (e.g., postmenopause); glands become "back-to-back" with minimal stroma. This is a precursor to cancer.

    • Benign Prostatic Hyperplasia (BPH): Enlarged prostate in elderly men due to androgens.

    • Important Exception: Unlike other pathologic hyperplasias, BPH is not associated with an increased risk of prostate cancer.

Atrophy: Mechanisms and Pathological Manifestations

  • Definition: Reduction in organ or tissue size due to a decrease in cell number or size.

  • Physiologic Atrophy: Occurs during normal development (e.g., embryonic structures like the notochord).

  • Pathologic Atrophy Causes:

    • Decreased Hormone Stimulation: Endometrial thinning after menopause.

    • Disuse Atrophy: Occurs in immobilized limbs (loss of muscle fibers, bone mass/osteopenia, and proteoglycans in cartilage).

    • Denervation Atrophy: Small, angulated skeletal muscle fibers seen after nerve loss.

    • Decreased Blood Supply: Renal artery stenosis leads to an atrophic kidney; atherosclerosis leads to senile brain atrophy (narrow gyri, wide sulci).

    • Inadequate Nutrition: Marasmus or cachexia (muscle wasting and loss of adipose tissue).

    • Pressure: Abdominal aortic aneurysm pushing on vertebrae; a cyst pushing on the pituitary gland.

  • Mechanisms of Atrophy:

    1. Ubiquitin-Proteasome Pathway: Damaged or aged proteins are tagged by ubiquitin ligase and digested by proteasomes into amino acids.

    2. Autophagy: The cell creates an autophagosome to engulf and digest its own damaged organelles (self-eating).

  • Clinical Correlates of Autophagy:

    • Alzheimer’s Disease: Accelerated formation of autophagosomes contributes to neurodegeneration.

    • Huntington’s Disease: Mutant huntingtin impairs the autophagy process.

    • Infectious Disease: Pathogens (Mycobacteria, Shigella, HSV-one) are often degraded via autophagy.

    • Inflammatory Bowel Disease (IBD): Defects in autophagy are linked to Crohn’s and Ulcerative Colitis.

Metaplasia: Adaptation and Malignant Potential

  • Definition: A reversible change where one differentiated cell type is replaced by another to withstand stress. This occurs via reprogramming of local tissue stem cells.

  • Types and Examples:

    • Squamous Metaplasia (Columnar to Squamous): Seen in the bronchi of smokers (loss of cilia and mucus clearance) and the cervix (transformation zone).

      • Vitamin A Deficiency: Causes squamous metaplasia in respiratory epithelium and the cornea (known as "toe spots" or Bitot’s spots, often involving Corynebacterium).

      • Bladder: Chronic irritation (Schistosomiasis, catheters, calculi) leads to squamous metaplasia and increased cancer risk.

    • Glandular Metaplasia (Squamous to Glandular): Classic example is Barrett’s Esophagus due to acid reflux.

      • Intestinal Metaplasia: Presence of goblet cells in the esophagus signifies the highest risk for progression to adenocarcinoma.

    • Connective Tissue Metaplasia: Formation of bone/cartilage in soft tissues (e.g., osseous metaplasia).

      • Myositis Ossificans: Bone formation within muscle after severe trauma (e.g., hit from a baseball bat). Exception: This type of metaplasia does not increase cancer risk.

  • Cancer Risk Principle: If metaplasia progresses to cancer, the cancer will be the same cell type as the metaplastic tissue (e.g., squamous metaplasia leads to squamous cell carcinoma; glandular metaplasia leads to adenocarcinoma).

Dysplasia: Disordered Growth and Pre-malignancy

  • Definition: Disordered growth and pre-malignant change characterized by a loss of uniformity and architectural orientation.

  • Key Histological Features:

    • Pleomorphism: Cells vary in size and shape.

    • Abnormal Nuclei: Large, dark (hyperchromatic), crowded, and overlapping.

    • Increased N:CN:C Ratio: The nucleus takes up a larger proportion of the cell volume.

    • Clumped Chromatin.

  • Clinical Staging (e.g., Cervix): Mild (lower layer), Moderate, or Severe/CIN 3 (full thickness).

Intracellular Accumulations: Metabolic and Exogenous Derangements

  • Mechanism 1: Fatty Change (Steatosis): Accumulation of triglycerides (large, clear vacuoles) in parenchymal cells. Primarily seen in the liver due to ethanol consumption or obesity (NAFLD).

    • Ethanol Pathway: Increases free fatty acid catabolism and triglyceride synthesis.

  • Mechanism 2: Cholesterol Accumulation:

    • Atherosclerosis: Cholesterol esters in intimal macrophages/smooth muscles create foam cells (small, foamy vacuoles).

    • Cholesterol Clefts: Long, needle-shaped crystals formed when cells rupture and release lipids.

    • Xanthomas: Lumpy, yellow cholesterol deposits in the skin or tendons seen in hyperlipidemic states.

    • Cholesterolosis: "Strawberry gallbladder" characterized by yellow flecks of cholesterol in the lamina propria.

    • Niemann-Pick Disease: Enzyme mutation causing cholesterol buildup in multiple organs.

  • Mechanism 3: Protein Accumulation:

    • Eosinophilic Droplets: Proteins appear as rounded, red (eosinophilic) deposits.

    • Russell Bodies: Compacted immunoglobulins in the plasma cells of patients with multiple myeloma.

    • Alpha-one Antitrypsin Deficiency: Misfolded proteins accumulate in the liver (PAS-positive droplets).

      • Clinical Presentation: A young non-smoker with both liver disease and emphysema.

    • Cytoskeletal Proteins: Mallory hyaline in alcoholic liver disease (fibrillar) and neurofibrillary tangles in Alzheimer’s.

  • Mechanism 4: Hyaline Change: A homogeneous, glassy pink appearance. In vessel walls, it indicates extravasated plasma proteins due to chronic hypertension or diabetes.

Questions & Discussion

  • Question: A 19-year-old female breastfed for one year; which process in the breast allowed this?

    • Answer: Lobular hyperplasia. Progesterone and hormonal stimulation increase the number of lobules.

  • Question (UWorld): A 53-year-old man with chronic heartburn (reflux) shows columnar epithelium with goblet cells on endoscopy. What similar adaptive response is seen elsewhere?

    • Context: The patient has Barrett’s Esophagus (glandular metaplasia).

    • Comparison: Bronchial epithelial cells in a smoker change to squamous via metaplasia.

    • Distinctions: Psoriasis is hyperplasia; breast mammary cells in cancer involve dysplasia; LVH is hypertrophy; limb immobility is atrophy.